Decitabine
Showing 51 - 75 of 493
Relapase and Refractory B-cell Non-Hodgkin's Lymphoma, Decitabine-primed Tandem CD19/CD20 CAR T Cells Trial in Beijing
Recruiting
- Relapase and Refractory B-cell Non-Hodgkin's Lymphoma
- Decitabine-primed Tandem CD19/CD20 CAR T Cells
- Decitabine-primed Tandem CAR19/20 engineered T cells
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
Mar 24, 2022
Acute Myeloid Leukemia Trial in Columbus (Decitabine, Nivolumab, Venetoclax)
Suspended
- Acute Myeloid Leukemia
- Decitabine
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 5, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +5 more
- Decitabine and Cedazuridine
- Nivolumab
-
New York, New YorkNY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
Jul 8, 2022
AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022
Sickle Cell Disease Trial in Chicago (Nicotinamide)
Recruiting
- Sickle Cell Disease
-
Chicago, IllinoisUniversity of Illinois at Chicago College of Medicine
Mar 21, 2022
Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)
Recruiting
- Malignant Melanoma
- Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
-
Aurora, ColoradoUniversity of Colorado Hospital
May 25, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult Trial in Saint Louis (Decitabine, Bone marrow biopsy/aspirate,
Terminated
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia, Relapsed, Adult
- Decitabine
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
May 9, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Decitabine and Cedazuridine
- Venetoclax
-
Houston, TexasM D Anderson Cancer Center
Apr 1, 2022
Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)
Terminated
- Pediatric Acute Myelogenous Leukemia (AML)
- Decitabine
-
Phoenix, Arizona
- +21 more
Jun 24, 2022
Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint
Recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
- Advanced Solid Tumors
- Chidamide
- +2 more
-
Beijing, Beijing, ChinaBiotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022
Esophageal Squamous Cell Carcinoma Trial (Decitabine plus Penpulimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Decitabine plus Penpulimab
- (no location specified)
Feb 23, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Azacitidine
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
May 16, 2022
Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)
Recruiting
- Acute Myeloid Leukemia
- SNDX-5613
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston
Recruiting
- Chronic Myelomonocytic Leukemia
- +3 more
- Decitabine
- Tagraxofusp-erzs
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Recurrent Trial in Italy (Decitabine 50 MG [Dacogen])
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- Pancreatic Adenocarcinoma Recurrent
- Decitabine 50 MG [Dacogen]
-
Milano, Italy
- +5 more
Jul 13, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Duarte (Decitabine, Pembrolizumab,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Decitabine
- +2 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Mar 9, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Bisantrene Dihydrochloride (high dose)
- +3 more
-
Newcastle, New South Wales, AustraliaCalvary Mater
Jul 14, 2022
Leukemia Trial in Houston (Vosaroxin, Decitabine)
Completed
- Leukemia
- Vosaroxin
- Decitabine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 13, 2022
Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- +3 more
- Dasatinib
- Decitabine and Cedazuridine
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With
Active, not recruiting
- Previously Treated Myelodysplastic Syndrome
- +7 more
- Decitabine
- Ipilimumab
-
Duarte, California
- +10 more
Jul 2, 2022
Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia
Recruiting
- Myelodysplastic Syndrome
- +2 more
- Navitoclax
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- CFI-400945
- +2 more
-
Duarte, California
- +7 more
Jul 20, 2022
Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)
Recruiting
- Acute Myeloid Leukemia
- rhTPO
- Decitabine
-
Shenyang, Liaoning, ChinaShengJing Hospital of China Medical University
May 16, 2022